More specifically, patients with poor prognosis showed signs of a heavier tumor-promoting immune infiltrate (e.g., M0 macrophages, memory B lymphocytes, and neutrophils), whereas cancer-unfavoring immune cells (e.g., CD8+ and CD4+ T cells, naïve B lymphocytes, monocytes, plasma cells, and activated mast cells) were found in specimens from patients with a better outcome [31]. Here, CD4 is linked to neoplasm.